why choose us

First received: August 23, 2023

Clinical Trial: Safety and Efficacy of the MyokinE100 (CL-EMS Alpha) Device in Inducing Visible Muscle Contraction in Healthy Volunteers

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: ICU Acquired Weakness

Study Type: INTERVENTIONAL


Official Title: Safety and Efficacy of the MyokinE100 (CL-EMS Alpha) Device in Inducing Visible Muscle Contraction in Healthy Volunteers

Brief Summary: Every patient admitted to the Intensive Care Unit (ICU) is at risk of developing "Intensive Care Unit Acquired Weakness" (ICUAW).ICUAW is associated with increased rate of mortality, prolonged duration of mechanical ventilation, ICU and hospital stay, rehabilitation time, and reduced quality of life.Currently, there is no effective treatment for ICUAW.Health Discovery Labs is conducting a research study to evaluate the safety of using an innovative experimental medical device in ICU settings that could…

Read more